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The Swedish Society of Chest Medicine has started a national register of patients on home mechanical ventilation,
to establish reliable national prevalence data and to accurately document patient and treatment characteristics to
enable a scientific evaluation of this treatment.
In this first collection of retrospective register data, covering patients on home mechanical ventilation at the
register start on 1 January 1996, we found 541 patients, corresponding to 61/100 000 inhabitants, using home
mechanical ventilation. Non-invasive ventilation, night-time ventilation and volume controlled ventilation
dominated.
We found four diagnosis categories of approximately equal size, namely post-polio, chest wall deformities,
neuromuscular diseases and ‘other diseases’. The age distribution was bimodal, with one small peak in the 20–29
year group and a large peak in the 60–69 year group. A survey of Danish patients on home mechanical ventilation
showed that they were considerably younger and that almost half of them suered from neuromuscular diseases.
Further work will be done to follow the situation in Sweden and in Denmark to elucidate the obvious dierences in
the selection of patients for home mechanical ventilation.
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Increasing numbers of patients on home mechanical
ventilation are reported from many centres (1). The French
organization ANTADIR reported a prevalence of 10/
100 000 inhabitants (2) in 1991, rising to 14/100 000 4–5
years later (Leger, personal communication). Data from
other countries usually show lower prevalence figures, but
may be highly unreliable, since few countries have national
organizations for collection and analysis of data on patients
on home mechanical ventilation. Reviewers often have
diculties in finding comparable data from dierent
countries (3), and national data often report a mixture of
patients on long-term oxygen and home mechanical
ventilation (4).
The Swedish Society of Chest Medicine has started a
national register of patients on home mechanical ventila-
tion, collecting data both retrospectively and prospectively
since 1 January 1996. The introduction of the register was
facilitated by the fact that the Society has run the Swedish
national oxygen register successfully for almost 10 yr (5).Received 18 May 1999 and accepted 31 August 1999.
Correspondence should be addressed to: Bengt Midgren, Dept of
Lung Medicine, University Hospital, SE-221 85 Lund, Sweden.
E-mail: bengt.midgren@lung.lu.se
0954-6111/00/020135+04 $35?00/0The primary aims of the register are to establish reliable
national prevalence data on home mechanical ventilation
and, for the retrospective part, to obtain some basic
medical and technical data. Secondary aims for the
prospective part (to be presented later) are to accurately
document patient and treatment characteristics and pul-
monary function data to enable a scientific evaluation of
this kind of treatment, to facilitate quality control and to
collect information on adverse experiences during home
mechanical ventilation.
The definitions of the variables collected in the Swedish
register were elaborated in close Swedish–Danish coopera-
tion. Both countries have publicly financed healthcare
systems and had a very similar cultural and socioeconomic
structure, which makes national comparisons of special
interest. Early data from Denmark and Sweden have been
briefly reported in the Nordic Medical Journal (Nordisk
Medicin) (6,7). Since interesting national dierences were
demonstrated in those reports, the authors of the Danish
report have kindly agreed to co-author the Discussion part
of the present analysis of Swedish data.
In this first report, we present retrospective cross-
sectional data for those patients who already were on
home mechanical ventilation on 1 January 1996. These
data will be discussed in relation to the situation in
Denmark.# 2000 HARCOURT PUBLISHERS LTD
FIG. 2. Diagnosis distribution for Swedish patients on
home mechanical ventilation 1996, according to register
data, and for Danish patients 1993–94 according to (6).
&: neuromuscular diseases; &: chest wall deformities
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From previous national inquiries and appeals in the
Swedish Medical Journal, we had a good general view of
the clinics and responsible physicians engaged in home
mechanical ventilation in Sweden. Information about the
new register was given during the autumn of 1995.
Registration forms and patient information leaflets were
sent to all chest clinics and other clinics known to manage
patients on home mechanical ventilation at the end of 1995.
Two reminder letters were sent during the spring of 1996,
and we were also in personal contact with some clinics.
The following data were registered for those patients who
were already on home mechanical ventilation on 1 January
1996: Age, sex, primary and secondary diagnoses, starting
year of home mechanical ventilation, type of ventilator,
type of connection, hours of ventilator use per day and
concomitant oxygen therapy.
The Swedish register has been approved by the Swedish
Data Inspection Board and the study has been approved by
the Medical Ethics Committee at the University of Lund.
All patients are given written information on the register
and are specifically asked by their physicians if they accept
registration.
Results
In Sweden (population 89 million), 541 patients (262
males), corresponding to 61/100 000 inhabitants, were
reported to use home mechanical ventilation on 1 January
1996. A total of 45 clinics reported patients to the Swedish
register. The 10 largest clinics accounted for more than 2/3
of the patients and 20 clinics reported less than three
patients.
The prevalence in our 26 health care regions varied
between 12 and 20/100 000 inhabitants. The age distribu-
tion for the patients is bimodal, which contrasts to the
Danish unimodal distribution, as illustrated in Fig. 1. The
major diagnosis groups are given in Fig. 2. The average
duration of therapy was 47 yr, and 9% of the patients had
had their ventilator therapy for more than 10 yr. Chest
physicians cared for 70% of the patients and 20% were
cared for by anaesthesiologists (mainly from one centre).FIG. 1 Age distribution for Swedish patients on home
mechanical ventilation 1996, according to register data,
and for Danish patients 1993–94 according to (6). &:
Sweden; &: Denmark.Technical data for the therapy are given in Table 1. Non-
invasive ventilation predominates and the therapy is
generally limited to night-time only. Volume controlled
ventilators were used by 75% of the patients, the fraction of
patients on pressure controlled ventilators has however
increased considerably in the prospective part of the
register, not reported in detail in this paper. Only 25%
had supplemental oxygen.
Discussion
The total prevalence of home mechanical ventilation in
Sweden on 1 January 1996, was slightly higher than that in
Denmark (61 vs. 5–55/100 000). From a previous survey of
this mode of therapy in the other Nordic countries (8), we
know that the prevalence in Norway and Finland is lower
than that of Denmark. Comparative figures from other
countries are dicult to obtain, but contemporary pre-
valence data amounting to 14/100 000 have been reported,
for example in France.
In Sweden, we estimate that there has been a doubling of
the number of patients during a 6-yr period preceding the start
of the register. A similar trend has also been reported from
Minnesota (1) and the doubling time in Denmark may have
been even shorter. Preliminary data from the years following(non-paralytic) : post-polio (/7 scoliosis); : other.
TABLE 1. Daily ventilator use for patients with tracheost-
omy and non-invasive connection respectively
Tracheostomy
connection
(25%)
Non-invasive
connection
(75%)
Daytime only 2 4
7–8 h day71 51 79
8–12 h day71 14 14
12–23 h day71 7 2
23–24 h day71 26 1
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new patients, but a low mortality rate. The net eect is an
increasing prevalence—a steady state is not yet reached.
There may be some missing data in the Swedish register.
Although few patients have refused registration, the
steering group may have failed in identifying all clinics
caring for patients on home mechanical ventilation. We
have, however, cross-checked our data with the companies
selling equipment for home mechanical ventilation to
ensure that all clinics likely to have patients were reached
by our information.
The distribution of diagnoses diers considerably be-
tween Sweden and Denmark (6,7). In Denmark, there is a
much higher assignment of home mechanical ventilation to
young muscular dystrophy patients than in Sweden.
Furthermore, Swedish figures for older patients with
deformities of the chest (idiopathic scoliosis, post polio
and post TBC) are considerably higher than those for
Denmark. This is demonstrated in Fig. 1, showing the age
distribution in Sweden and in Denmark.
These dierences in age distribution and diagnosis
pattern may have several explanations. Since the medical
regulations are very similar in Sweden and in Denmark,
other explanations must be sought. One is the Danish non-
profit association ‘Muskelsvindsfonden’ (The muscular
dystrophy fund). This organization acts not only as a
pressure group for the benefit of patients with muscular
dystrophy, but also as a centre of excellence for improving
competence and education of health care professionals. We
believe that this may positively aect the inclination of
Danish paediatricians and neurologists to refer their
muscular dystrophy patients to centres for home mechan-
ical ventilation. Danish patients with Duchenne’s muscular
dystrophy have obviously adopted the ventilator as a part
of their ‘natural’ life course.
Another explanation has to do with the speciality of
those physicians involved in home mechanical ventilation.
In Denmark, the two centres for home mechanical
ventilation are managed by anaesthesiologists, who see
only those patients who are ‘filtered’ by other specialists.
The relative lack of older patients in the Danish material
contrasts with the bimodal age distribution found not only
in Sweden but also in France (4), and therefore may
represent a true under-utilization of home mechanical
ventilation in this patient group in Denmark.
There are some features that distinguish the Swedish
diagnosis panorama from that in, for example, France or
the U.S.A. In this article, we report low fractions of
patients with amyotrophic lateral sclerosis (ALS) (51%),
and chronic obstructive pulmonary disease (COPD) (3–
4%). The percentage of new ALS and COPD patients on
home mechanical ventilation reported to the register (the
prospective part, not analysed in this article) is still rather
low, approximately 4–5%. Thus, there seems to be very
little enthusiasm among Swedish physicians to oer
patients with these diagnoses home mechanical ventilation.
There are, however, no national regulations prohibiting the
use of home mechanical ventilation in this type of patients
and the first Swedish guidelines, published by the Swedish
Society of Chest Medicine 1998, leave the question open.Some of the large dierences in the number of patients on
home mechanical ventilation in dierent countries may be
explained by dierent national systems for the provision of
healthcare, rather than by actual dierences in the
prevalence of the underlying diseases. In Sweden, as well
as in Denmark, patients have, at least nowadays, free access
to ventilatory devices regardless of insurances, personal
financial prerequisites etc. We have, however, shown that
there may be large dierences, even if the healthcare
systems are homogenous or very similar. One likely
explanation for this is that the indications for home
mechanical ventilation are not well defined, which (for
good or for bad) may make room for more individual
decision making. In a review of ventilator use by muscular
dystrophy association patients (9), Bach points out that
there are tremendous dierences in the utilization of home
mechanical ventilation between dierent clinics.
The sleep apnoea syndrome poses a problem of
classification, since some patients with this syndrome use
pressure-controlled ventilators (e.g. BiPAP2 Respironics
Inc., U.S.A.) due to intolerance of nasal CPAP, while other
patients use ventilators to control overt hypoventilation.
Only the latter category is included in the Swedish register.
Misclassification of sleep apnoea patients may, at most,
account for 10% of the county-specific variation in
prevalence of home mechanical ventilation.
Analysis of clinical patient data from the Swedish
counties with the highest prevalence rates (15–20/100 000)
does not reveal any strikingly dierent features when
compared to data the country as a whole. Thus, there are
no indications of over-prescription in these counties.
Preliminary analysis of more recent data from the register
indicate a net annual increase of approx 10%, with no
dierence between counties with high and with low
prevalence rates.
We therefore conclude that the prevalence of home
mechanical ventilation will probably continue to rise in
most regions, a steady-state has, to our knowledge, not yet
been reached in any country or region. There is a lot of
work to be done in low-prevalence regions to catch up with
the development in the high-prevalence regions, both
nationally and internationally.
References
1. Adams AB, Whitman J, Marcy T. Surveys of long-term
ventilatory support in Minnesota: 1996 and 1992. Chest
1993; 103: 1463–1469
2. Muir JF, Voisin C, Ludot A. Organization of home
respiratory care: the experience in France with ANTA-
DIR. Monaldi Arch Chest Dis 1993; 48: 462–467.
3. Fauroux B, Howard P, Muir JF. Home treatment for
chronic respiratory insuciency: the situation in Europe
in 1992. Eur Respir J 1994; 7: 1721–1726.
4. Chailleux E, Faroux B, Binet F, Dautzenberg B, Polu
J-M. Predictors of survival in patients receiving
domiciliary oxygen therapy or mechanical ventilation.
138 B. MIDGREN ET AL.A 10-year analysis of ANTADIR observatory. Chest
1996; 109: 741–749.
5. Stro¨m K. Experience with an oxygen registry in Sweden.
In O’Donohue WJ, Long-term oxygen therapy. Scientific
basis and clinical application. pp. 331–346.
6. Jacobsen E, Nørregaard O, Juhl, B. To centre initierer
hjemmerespiratorbehandlingen i Danmark Two centres
initiate home respirator treatment in Denmark]. Nord
Medical J 1995; 110: 146–147.7. Midgren B, Olofson J, Harlid R. Stark o¨kning i Sverige
av respiratorbehandling i hemmet [Considerable in-
crease in home respirator treatment in Sweden]. Nord
Medical J 1995; 110: 149–150.
8. Midgren B. Respiratorbehandling i hemmet i Norden
[home respiratory care in Scandinavia (editorial)]. Nord
Medical J 1995; 110: 142–144.
9. Bach JR. Ventilator use by muscular dystrophy associa-
tion patients. Arch Phys Med Rehabil 1992; 73: 179–183.
